4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060765
EVP and Chief Medical Officer sold 359 shares at $81.14 ($29,129)
From the SEC's structured data for this filing
Trades in this filing
Bedrosian Camille L · EVP and Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-14 | Sale : show line 1 in the form | −359 | $81.14 | $29,129 | 38,416 | D |
| Open-market sales · 359 sh · avg $81.14 · $29,129 | ||||||
Loading xslF345X03/doc4.xml…